The absorption behavior of cyclosporin A lecithin vesicles in rat intestinal tissue
- PMID: 12878392
- DOI: 10.1016/s0378-5173(03)00274-6
The absorption behavior of cyclosporin A lecithin vesicles in rat intestinal tissue
Abstract
The purpose of the study was to investigate the absorption behavior of lecithin vesicles of cyclosporin A (CsA-VES), prepared by the rotary evaporation method and treated further with sonication. The everted gut sac technique and in situ circulation method were used to examine: (1) relationship between the CsA-VES absorption velocity and the CsA-VES content; (2) the influence of the intestinal mucus, blank vesicles, concentration of Na(+), energy inhibitor and P-gp inhibitor on the absorption of CsA-VES; and (3) the respective accumulated content of CsA in the incubating medium and the sacs after incubation with Sandimmum Neoral((R))(CsA-NEO) and CsA-VES. Our results showed there was a saturated absorption of CsA. Most CsA-VES accumulated in the mucus before it reached the intestinal tissue. There was no significant difference in the accumulated absorption content in the incubating medium and the sacs of CsA-NEO and CsA-VES. The addition of blank vesicles and concentration of Na(+) had no significant influence on the accumulated absorption of CsA (P>0.05). The energy inhibitor and P-gp inhibitor influenced the accumulated absorption of CsA significantly (P<0.05). CsA-VES may be transported by phagocytosis. Mucus was a barrier blocking the diffusion of CsA-VES. CsA-NEO and CsA-VES showed equal absorption levels in the intestine.
Similar articles
-
Pharmacokinetic behavior of cyclosporin A in rabbits by oral administration of lecithin vesicle and Sandimmun Neoral.Int J Pharm. 2001 Mar 23;216(1-2):17-21. doi: 10.1016/s0378-5173(00)00680-3. Int J Pharm. 2001. PMID: 11274802
-
In situ intestinal absorption of cyclosporine A solid dispersion in rats.Drug Dev Ind Pharm. 2008 Jun;34(6):627-31. doi: 10.1080/03639040701833948. Drug Dev Ind Pharm. 2008. PMID: 18568913
-
Comparison of cyclosporin A absorption from LCT and MCT solutions following intrajejunal administration in conscious dogs.J Pharm Sci. 1996 Jun;85(6):666-8. doi: 10.1021/js9503791. J Pharm Sci. 1996. PMID: 8773966
-
Generic cyclosporine formulations: more open questions than answers.Transpl Int. 2005 Apr;18(4):371-8. doi: 10.1111/j.1432-2277.2005.00078.x. Transpl Int. 2005. PMID: 15773953 Review.
-
Distribution of cyclosporin in organ transplant recipients.Clin Pharmacokinet. 2002;41(9):615-37. doi: 10.2165/00003088-200241090-00001. Clin Pharmacokinet. 2002. PMID: 12126456 Review.
Cited by
-
Basics and recent advances in peptide and protein drug delivery.Ther Deliv. 2013 Nov;4(11):1443-67. doi: 10.4155/tde.13.104. Ther Deliv. 2013. PMID: 24228993 Free PMC article.
-
Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake.Int J Nanomedicine. 2011;6:3151-62. doi: 10.2147/IJN.S25741. Epub 2011 Dec 2. Int J Nanomedicine. 2011. PMID: 22163166 Free PMC article.
-
Phospholipids and lipid-based formulations in oral drug delivery.Pharm Res. 2010 Aug;27(8):1469-86. doi: 10.1007/s11095-010-0130-x. Epub 2010 Apr 22. Pharm Res. 2010. PMID: 20411409 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous